WPC Qʠi/{|8 >%Roʼn)oK4ypDDCV U} `;hY) jTQW8'@ly SUf1ST6|QwIp4@i<ƌֳd\+:B<򻲾Kwi2QZbvwY2FHuP$&Sv@&h͜TC0Z~UOڋA:ڍ̀B0f~3M-!3LOOJ}t'Dᕯ??3s-]&nԀDk aj^e0XJ= >3hM"ݞ^sXDsIn^A|jpHr|lշb։+˶ue} gz?%O苟vK@Q.$(`{wMСJ`ɢ갃-!cL x%z2)+W!m cԤf o}M1UN % 04 # ^^1 mw@4^  A @ |o)p+?pLXX 0UX 0@Y 0AZ 0?[ 0:\ 02] 0'^ 0_ 0` 0C` 07a 0&b 0c 0c 0d 0e 0f 0g 0@Yh 0h 0i 0nj 0Tk 07l 0m 0m 0n 0<o AMoV,p@ qoAq@ !o)-UNZh@ o N_ 0aa D-' 0KT 1 0Q0000 0Q 0]   0u// 0w 0 0 1u}} B6 72/ 1EEEEEEEEEEEEEEEEEEEEEU:V                                            e v&d9 Z6Times New Roman RegularX( Z$ IS , .\R6&A4\XħXXXTRW<6&A4W<6&A4 6&A4 6&A4T ? XXħ0?vvbX0#ggdd  8dXXd8ISUS.,    \\mimir.althingi.is\Austurstr 10 3h lp41tt0\\Mimir\forrit\WP2000\template\SKJRIT~1.WPT\\Mimir\forrit\WP2000\template\SkjritunY2k.wptU      Ӏ7.F.nW0BackupaJ.s 3|x[^] I&mage <=8C HKKKKLevel 1Level 2Level 3Level 4Level 5 WPC)vv"513980! !v*) &WordMicrosoft Word   z  "System 0- @Times New Romanbwbw0- z & .  -- z   UA   ''  ----'-- --'-- --'--  Arialw@ bwbw0- "Systemw@ bwbw0- Arialw@ bwbw0----'--  Arialw@5 bwbw0- -  Arialw@5 bwbw0- ---'--  Arialw@2 bwbw0- -------- -- -- -- -Arialw@ ˾bwbw0- ---'--  Arialw@ bwbw0- - -- -- - -- -- - -- -- - -- --  Small Fonts ~bwbw0-  Arialw@ Bbwbw0-- -- ---------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- ---'- --  ---'- --  --  $exxeex----'- --  seseLe L e ee@e@eexex---'- --  l-xe xexe---'- --  ---'- --   ---'- --  xe---'- --  ue-33- 33 $   $<KK<<$ppp$uuu$lll$ UU  U$=DLDL==D$o/~/~oo/$$$$<gKgK<<g$o ~ ~oo $###$;;;- $''$KZZKK$}}}$lll$OOO$7'7'7$LYYLL$~~~$$YYY$$&$&$$KZZKK$~~~$$---'- --  xe---'- --  -xe e-beLbLe b ebebe@b@ebebexbxeeee22ff33ee22ee----------'---  Oo  ]2 %9N05C - Svefnlyf og randi lyf (hypnotica og sedativa)            2 4ra Fjldi skilgreindra dagskammta 1000 ba skipt eftir kyni og aldri sust 6 mn. rsins 2001                             -----'---  ---'---  ----'---    2 T0u2 C:5.0002 210.0002 215.0002 {220.0002 7225.0002 230.0002 235.0002 o240.000---'---  ---'---    2 s0-4. 2 5-9.2 10-14.2 15-19.2 920-24.2 l25-29.2 30-34.2 35-39.2 40-44.2 945-49.2 l50-54.2 55-59.2 60-64.2 65-69.2 970-74.2 l75-79.2 80-84.2 85 og2 eldri.---'---  - -- -- ---'- --  S 2  Aldursbil   -- ---'- --  -- -- ---'- --  0  Arialw@L Ծbwbw0-B2 'DDD hverja 1000 ba hvers aldursbils            - -- ---'- --  - -  l---'- --  k---'- --  k-33- 33  2  Karlar ---'- --  k---'- --  k--  <4 2 @Konur ---'- --  k---'- --  ---'- --  ---'  ' '  --'     --'&' 2 T z --WPWin 6.0/OLE 1.0 Prefix Information MarkerWPDraw30.Drawingbࡱ>   !"#$%&'()*+,-./Root Entry`.@p@@Ole WPG20)CompObjt!) `.@pCorel Presentations 9 Drawing Embed SourceWPDraw30.Drawing9qPObject(s) forward one72NObject(s) back one2IWPC)vv"513980! !v*) &WordMicrosoft Word   z  "System 0- @Times New Romanbwbw0- z & .  -- z   UA   ''  ----'-- --'-- --'--  Arialw@ bwbw0- "Systemw@ bwbw0- Arialw@ bwbw0----'--  Arialw@5 bwbw0- -  Arialw@5 bwbw0- ---'--  Arialw@2 bwbw0- -------- -- -- -- -Arialw@ ˾bwbw0- ---'--  Arialw@ bwbw0- - -- -- - -- -- - -- -- - -- --  Small Fonts ~bwbw0-  Arialw@ Bbwbw0-- -- ---------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- ---'- --  ---'- --  --  $exxeex----'- --  seseLe L e ee@e@eexex---'- --  l-xe xexe---'- --  ---'- --   ---'- --  xe---'- --  ue-33- 33 $   $<KK<<$ppp$uuu$lll$ UU  U$=DLDL==D$o/~/~oo/$$$$<gKgK<<g$o ~ ~oo $###$;;;- $''$KZZKK$}}}$lll$OOO$7'7'7$LYYLL$~~~$$YYY$$&$&$$KZZKK$~~~$$---'- --  xe---'- --  -xe e-beLbLe b ebebe@b@ebebexbxeeee22ff33ee22ee----------'---  Oo  ]2 %9N05C - Svefnlyf og randi lyf (hypnotica og sedativa)            2 4ra Fjldi skilgreindra dagskammta 1000 ba skipt eftir kyni og aldri sust 6 mn. rsins 2001                             -----'---  ---'---  ----'---    2 T0u2 C:5.0002 210.0002 215.0002 {220.0002 7225.0002 230.0002 235.0002 o240.000---'---  ---'---    2 s0-4. 2 5-9.2 10-14.2 15-19.2 920-24.2 l25-29.2 30-34.2 35-39.2 40-44.2 945-49.2 l50-54.2 55-59.2 60-64.2 65-69.2 970-74.2 l75-79.2 80-84.2 85 og2 eldri.---'---  - -- -- ---'- --  S 2  Aldursbil   -- ---'- --  -- -- ---'- --  0  Arialw@L Ծbwbw0-B2 'DDD hverja 1000 ba hvers aldursbils            - -- ---'- --  - -  l---'- --  k---'- --  k-33- 33  2  Karlar ---'- --  k---'- --  k--  <4 2 @Konur ---'- --  k---'- --  ---'- --  ---'  ' '  --'     --'&' 2 T z --  ! L              BOlePartOlePres000f*WPGExtents I0$$*   $I0   I   H. &WordMicrosoft Word   z  "Systemw@  bwbw0- @Times New Romanbwbw0- z & .  -- z   UA   ''  ----'-- --'-- --'--  Arialw@S bwbw0- "Systemw@A (bwbw0- Arialw@S bwbw0----'--  Arialw@ bwbw0- -  Arialw@ bwbw0- ---'--  Arialw@U $bwbw0- -------- -- -- -- -Arialw@j 9bwbw0- ---'--  Arialw@ bwbw0- - -- -- - -- -- - -- -- - -- --  Small Fonts  nbwbw0-  Arialw@ "bwbw0-- -- ---------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- ---'- --  ---'- --  --  $exxeex----'- --  seseLe L e ee@e@eexex---'- --  l-xe xexe---'- --  ---'- --   ---'- --  xe---'- --  ue-33- 33 $   $<KK<<$ppp$uuu$lll$ UU  U$=DLDL==D$o/~/~oo/$$$$<gKgK<<g$o ~ ~oo $###$;;;- $''$KZZKK$}}}$lll$OOO$7'7'7$LYYLL$~~~$$YYY$$&$&$$KZZKK$~~~$$---'- --  xe---'- --  -xe e-beLbLe b ebebe@b@ebebexbxeeee22ff33ee22ee----------'---  Oo  ]2 %9N05C - Svefnlyf og randi lyf (hypnotica og sedativa)            2 4ra Fjldi skilgreindra dagskammta 1000 ba skipt eftir kyni og aldri sust 6 mn. rsins 2001                             -----'---  ---'---  ----'---    2 T02 C:5.0002 210.0002 215.0002 {220.0002 7225.0002 230.0002 235.0002 o240.000---'---  ---'---    2 s0-4. 2 5-9.2 10-14.2 15-19.2 920-24.2 l25-29.2 30-34.2 35-39.2 40-44.2 945-49.2 l50-54.2 55-59.2 60-64.2 65-69.2 970-74.2 l75-79.2 80-84.2 85 og2 eldri.---'---  - -- -- ---'- --  S 2  Aldursbil   -- ---'- --  -- -- ---'- --  0  Arialw@D bwbw0-B2 'DDD hverja 1000 ba hvers aldursbils            - -- ---'- --  - -  l---'- --  k---'- --  k-33- 33  2  Karlar ---'- --  k---'- --  k--  <4 2 @Konur ---'- --  k---'- --  ---'- --  ---'  ' '  --'     --'&' 2 T z -- x  8@8@ANANI METAFILEPICTI0 ,*I0$   $I0   I   H. &WordMicrosoft Word   z  "Systemw@  bwbw0- @Times New Romanbwbw0- z & .  -- z   UA   ''  ----'-- --'-- --'--  Arialw@S bwbw0- "Systemw@A (bwbw0- Arialw@S bwbw0----'--  Arialw@ bwbw0- -  Arialw@ bwbw0- ---'--  Arialw@U $bwbw0- -------- -- -- -- -Arialw@j 9bwbw0- ---'--  Arialw@ bwbw0- - -- -- - -- -- - -- -- - -- --  Small Fonts  nbwbw0-  Arialw@ "bwbw0-- -- ---------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- ---'- --  ---'- --  --  $exxeex----'- --  seseLe L e ee@e@eexex---'- --  l-xe xexe---'- --  ---'- --   ---'- --  xe---'- --  ue-33- 33 $   $<KK<<$ppp$uuu$lll$ UU  U$=DLDL==D$o/~/~oo/$$$$<gKgK<<g$o ~ ~oo $###$;;;- $''$KZZKK$}}}$lll$OOO$7'7'7$LYYLL$~~~$$YYY$$&$&$$KZZKK$~~~$$---'- --  xe---'- --  -xe e-beLbLe b ebebe@b@ebebexbxeeee22ff33ee22ee----------'---  Oo  ]2 %9N05C - Svefnlyf og randi lyf (hypnotica og sedativa)            2 4ra Fjldi skilgreindra dagskammta 1000 ba skipt eftir kyni og aldri sust 6 mn. rsins 2001                             -----'---  ---'---  ----'---    2 T02 C:5.0002 210.0002 215.0002 {220.0002 7225.0002 230.0002 235.0002 o240.000---'---  ---'---    2 s0-4. 2 5-9.2 10-14.2 15-19.2 920-24.2 l25-29.2 30-34.2 35-39.2 40-44.2 945-49.2 l50-54.2 55-59.2 60-64.2 65-69.2 970-74.2 l75-79.2 80-84.2 85 og2 eldri.---'---  - -- -- ---'- --  S 2  Aldursbil   -- ---'- --  -- -- ---'- --  0  Arialw@D bwbw0-B2 'DDD hverja 1000 ba hvers aldursbils            - -- ---'- --  - -  l---'- --  k---'- --  k-33- 33  2  Karlar ---'- --  k---'- --  k--  <4 2 @Konur ---'- --  k---'- --  ---'- --  ---'  ' '  --'     --'&' 2 T z -- x  8@8@AWPWin 6.0/OLE 1.0 Prefix Information MarkerWPDraw30.Drawingbࡱ>   !"#$%&'()*+,-./Root Entry`.@ppzC@Ole WPG20)CompObjtS `.@pCorel Presentations 9 Drawing Embed SourceWPDraw30.Drawing9qP( ,Object(s) forward one72N Object(s) back one2IWPC)22"513980! !2t) &WordMicrosoft Word  i  "System 0- @Times New Romanbwbw0-i & j.  --ii   UA   ''  ----'-- --'-- --'--  Arialw@! 5bwbw0- "Systemw@) {bwbw0- Arialw@! 6bwbw0----'--  Arialw@, bwbw0- -  Arialw@, bwbw0- ---'--  Arialw@I lbwbw0- -------- -- -- -- -Arialw@ .bwbw0- ---'--  Arialw@ bwbw0- - -- -- - -- -- - -- -- - -- --  Small Fonts bwbw0-  Arialw@ >bwbw0-- -- ---------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- ---'- --  ---'- --  --  $exxeex----'- --  seseCe Cee]e]eexex---'- --  k-xe xexe---'- --  ---'- --   ---'- --  xe---'- --  ue-33- 33 $o~~oo$$$   $<KK<<$nt}t}nnt$ggg$OOO$$; J J;; $o~~oo$$kkk$]]]$:WIWI::W$n}}}}nn}$$- $~~~$$$''$K{Y{YKK{$}kk}}k$QQQ$,,,$&&$JYYJJ$~GG~~G$   $$%%$IXXII$}}}$$---'- --  xe---'- --  -xe e-beCbCebebe]b]ebebexbxeeee22dd11ee00dd----------'---  Ow  Z2 >7N05B - Randi og kvastillandi lyf (anxiolytica) m          2 4y^Fjldi skilgreindra dagskammta 1000 ba skipt eftir kyni og aldri sust 6 mn. rsins 2001                            -----'---  ---'---  ----'---    2 T02 9:2.0002 :4.0002 :6.0002 T:8.0002 210.0002 212.0002 o214.000---'---  ---'---    2 s0-4. 2 5-9.2 10-14.2 15-19.2 920-24.2 l25-29.2 30-34.2 35-39.2 40-44.2 845-49.2 k50-54.2 55-59.2 60-64.2 65-69.2 870-74.2 k75-79.2 80-84.2 85 og2 eldri.---'---  - -- -- ---'- --  S 2  Aldursbil   -- ---'- --  -- -- ---'- --  0  Arialw@ bwbw0-B2 'DDD hverja 1000 ba hvers aldursbils            - -- ---'- --  - -  k---'- --  j---'- --  j-33- 33  2 Karlar ---'- --  j---'- --  j--  ;3 2 ?Konur ---'- --  j---'- --  ---'- --  ---'  ' '  --'     --'&' 2   i --BOlePartOlePres000*WPGExtents 0* n* 7  * 0   N   M. &WordMicrosoft Word  i  "Systemw@  bwbw0- @Times New Romanbwbw0-i & j.  --ii   UA   ''  ----'-- --'-- --'--  Arialw@ bwbw0- "Systemw@ bwbw0- Arialw@ bwbw0----'--  Arialw@ bwbw0- -  Arialw@ bwbw0- ---'--  Arialw@ ޾bwbw0- -------- -- -- -- -Arialw@ [bwbw0- ---'--  Arialw@! bwbw0- - -- -- - -- -- - -- -- - -- --  Small Fonts ybwbw0-  Arialw@, {bwbw0-- -- ---------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- ---'- --  ---'- --  --  $exxeex----'- --  seseCe Cee]e]eexex---'- --  k-xe xexe---'- --  ---'- --   ---'- --  xe---'- --  ue-33- 33 $o~~oo$$$   $<KK<<$nt}t}nnt$ggg$OOO$$; J J;; $o~~oo$$kkk$]]]$:WIWI::W$n}}}}nn}$$- $~~~$$$''$K{Y{YKK{$}kk}}k$QQQ$,,,$&&$JYYJJ$~GG~~G$   $$%%$IXXII$}}}$$---'- --  xe---'- --  -xe e-beCbCebebe]b]ebebexbxeeee22dd11ee00dd----------'---  Ow  Z2 >7N05B - Randi og kvastillandi lyf (anxiolytica)          2 4y^Fjldi skilgreindra dagskammta 1000 ba skipt eftir kyni og aldri sust 6 mn. rsins 2001                            -----'---  ---'---  ----'---    2 T02 9:2.0002 :4.0002 :6.0002 T:8.0002 210.0002 212.0002 o214.000---'---  ---'---    2 s0-4. 2 5-9.2 10-14.2 15-19.2 920-24.2 l25-29.2 30-34.2 35-39.2 40-44.2 845-49.2 k50-54.2 55-59.2 60-64.2 65-69.2 870-74.2 k75-79.2 80-84.2 85 og.2 eldri.---'---  - -- -- ---'- --  S 2  Aldursbil   -- ---'- --  -- -- ---'- --  0  Arialw@k bwbw0-B2 'DDD hverja 1000 ba hvers aldursbils            - -- ---'- --  - -  k---'- --  j---'- --  j-33- 33  2 Karlar ---'- --  j---'- --  j--  ;3 2 ?Konurr ---'- --  j---'- --  ---'- --  ---'  ' '  --'     --'&' 2   i --   ,NANI METAFILEPICT0v*0*  7  * 0   N   M. &WordMicrosoft Word  i  "Systemw@  bwbw0- @Times New Romanbwbw0-i & j.  --ii   UA   ''  ----'-- --'-- --'--  Arialw@ bwbw0- "Systemw@ bwbw0- Arialw@ bwbw0----'--  Arialw@ bwbw0- -  Arialw@ bwbw0- ---'--  Arialw@ ޾bwbw0- -------- -- -- -- -Arialw@ [bwbw0- ---'--  Arialw@! bwbw0- - -- -- - -- -- - -- -- - -- --  Small Fonts ybwbw0-  Arialw@, {bwbw0-- -- ---------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- ---'- --  ---'- --  --  $exxeex----'- --  seseCe Cee]e]eexex---'- --  k-xe xexe---'- --  ---'- --   ---'- --  xe---'- --  ue-33- 33 $o~~oo$$$   $<KK<<$nt}t}nnt$ggg$OOO$$; J J;; $o~~oo$$kkk$]]]$:WIWI::W$n}}}}nn}$$- $~~~$$$''$K{Y{YKK{$}kk}}k$QQQ$,,,$&&$JYYJJ$~GG~~G$   $$%%$IXXII$}}}$$---'- --  xe---'- --  -xe e-beCbCebebe]b]ebebexbxeeee22dd11ee00dd----------'---  Ow  Z2 >7N05B - Randi og kvastillandi lyf (anxiolytica)          2 4y^Fjldi skilgreindra dagskammta 1000 ba skipt eftir kyni og aldri sust 6 mn. rsins 2001                            -----'---  ---'---  ----'---    2 T02 9:2.0002 :4.0002 :6.0002 T:8.0002 210.0002 212.0002 o214.000---'---  ---'---    2 s0-4. 2 5-9.2 10-14.2 15-19.2 920-24.2 l25-29.2 30-34.2 35-39.2 40-44.2 845-49.2 k50-54.2 55-59.2 60-64.2 65-69.2 870-74.2 k75-79.2 80-84.2 85 og.2 eldri.---'---  - -- -- ---'- --  S 2  Aldursbil   -- ---'- --  -- -- ---'- --  0  Arialw@k bwbw0-B2 'DDD hverja 1000 ba hvers aldursbils            - -- ---'- --  - -  k---'- --  j---'- --  j-33- 33  2 Karlar ---'- --  j---'- --  j--  ;3 2 ?Konurr ---'- --  j---'- --  ---'- --  ---'  ' '  --'     --'&' 2   i --   ,*+ (_2623  ..*S+Y (_25   ;1` hp x (#%;23  ..  A7X` hp x (#%A  *P+Y (_24   8.` hp x (#%823  ..  A7X` hp x (#%A  *M+Y (_23  ` 5+` ` hp x (#%523  ..  A7X` hp x (#%A  *J+Y (_22   2( hp x (#%223  ..  A7X` hp x (#%A  *G+Y (_21   /% hp x (#%/23  ..  A7X` hp x (#%A  *D+Y (_20  h ,"h hp x (#%,23  ..  A7X` hp x (#%A  *A+Y (_19   ) p x (#%)23  ..  A7X` hp x (#%A  *>+Y (_18   &p x (#%&23  ..  A7X` hp x (#%A  * (_1723  Ԁ*SY (_16   ;1` hp x (#%;23  Ԁ  A7X` hp x (#%A  *PY (_15   8.` hp x (#%823  Ԁ  A7X` hp x (#%A  *MY (_14  ` 5+` ` hp x (#%523  Ԁ  A7X` hp x (#%A  *JY (_13   2( hp x (#%223  Ԁ  A7X` hp x (#%A  *GY (_12   /% hp x (#%/23  Ԁ  A7X` hp x (#%A  *DY (_11  h ,"h hp x (#%,23  Ԁ  A7X` hp x (#%A  *AY (_10   ) p x (#%)23  Ԁ  A7X` hp x (#%A  (>Y &_9   &p x (#%&23  Ԁ  A7X` hp x (#%A  ( &_823  (SY &_7   ;1` hp x (#%;23   A7X` hp x (#%A  (PY &_6   8.` hp x (#%823   A7X` hp x (#%A  (MY &_5  ` 5+` ` hp x (#%523   A7X` hp x (#%A  (JY &_4   2( hp x (#%223   A7X` hp x (#%A  (GY &_3   /% hp x (#%/23   A7X` hp x (#%A  (DY &_2  h ,"h hp x (#%,23   A7X` hp x (#%A  (AY &_1   ) p x (#%)23   A7X` hp x (#%A  &>Y $_   &p x (#%&23   A7X` hp x (#%A  <:Default Para[^]A<< c L et)ISUS.,,,..7XXXX? 7:,XX0?vvbX0#ggdd  ISIS,.   _>? Ҁ4 WPC  ! FAƚ K  v&WordMicrosoft Word  W  "System 0- @Times New Romanbwbw0-W & X.  --WW   W &WordMicrosoft Word W  "Systemw@ ɾbwbw0-@Times New Romanbwbw0-   2  W ---- !& '---&&O --%'M --&&&tO w--%'uM u--&&&O --%'M --&&&O --%'M --&&& O --%' M --&&&O --%'M --&&& O #--%'!M !--&&&O --%'M --&&&.O 1--%'/M /--&&&O --%'M --&--bN '---- bZK-- -- b*-- -- b-- -- bP-- -- b6{-- -- b=-- -- b V-- -- b;-- -- b-- -- ba-- -- bA -- -- b>-- -- b 2g -- -- bF  -- -- b  -- -- b l -- -- bL  -- -- b j -- -- b[B)-- -- b -- -- b-- -- bf5-- -- bd-- -- b-- -- bl:-- -- b9-- -- b-- -- bq@-- -- b N-- -- b  -- -- bv yE -- -- b%  -- -- b  -- -- b| 9K -- -- b*  -- &&)b--%''`--&&_)c--%`'a--&&)--%'--&&t)w--%u'u--&&)--%'--&&)--%'--&& )--% ' --&&)--%'--&& )#--%!'!--&&)--%'--&&.)1--%/'/--&&)--%'--&&&_O c--%'`M a--&&&_)o--%'m'`--&&_o--%m`--&&}_o--%~m~`--&&+_.o--%,m,`--&&_o--%m`--&&_o--%m`--&&1_4o--%2m2`--&&_o--%m`--&&_o--%m`--&&<_?o--%=m=`--&&_o--%m`--&&_o--%m`--&&A _E o--%B mC `--&& _ o--% m `--&& _ o--% m `--&&G _J o--%H mH `--&& _ o--% m `--&& _ o--% m `--&&L _O o--%M mM `--&-- ]-- ]@"Arialw@\ bwbw0-72 ^] vsanir gedeyfarlyf 2001.&%%)%)%()&#)%#%%%%- 2 B] .'--+ 5--* 6- v2 6G6 *Fjldi skilgreindra dagskammta (SDS) dag 1000 ba hvers aldursbilsE)))%%)%))%)%)%%%;<%-0-%)%)$%%%%))%)%%%%))%)%- 2 4 6 * ,'--(H--(H@"Antique Olive Romanbw0-   2 OH'0- 2 H' -'--.--.-  2 -20- 2 - 0-'--.\--.\-  2 c\-40- 2 2\- 0-'--,.--*.-  2 -*60- 2 -* 0-'--.j--.j-  2 qj-80- 2 @j- 0-'--?(-->'-  2 &>100- 2 &> 0.'--(~--'~-  2 ~&120- 2 T~& 0.'--S(--R'-  2 &R140- 2 &R 0.'--(--'-  2 &160- 2 b& 0.'--a(--`'-  2 &`180- 2 &` 0.'--4--3-  2 2200- 2 v2 0.'--]--]-   2 ]]00 2 t]-0 2 ]40- 2 c] 0.'--m --l -   2   k50 2 # k-0 2 3 k90- 2 cJ k 0.'-------  2 ,10 2 ,-02 ,14- 2 c, 4.'--P--Q-  2 QQ15 2 Q-52 Q19- 2 cQ 9.'-----  2 20 2 '-02 724- 2 ce 4.'--E--D-  2 C25 2 C-52 C29- 2 cC 9.'--V--V-  2 VV30 2 V-02 V34- 2 cV 4.'-----  2 35 2 ,-52 <39- 2 cj 9.'--P--P-  2 O40 2 O-02 O44- 2 cO 4.'--[--[-  2 [[45 2 [-52 [49- 2 c[ 9.'-- -- -  2   50 2 8 -02 H 54- 2 cv  4.'--C --C -  2 B 55 2 B -52 B 59- 2 c B  9.'-- ` -- a -  2 a a  60 2  a  -02  a  64- 2 c a   4.'--  --  -  2    65 2 =   -52 M   69- 2 c{    9.'--O  --O  -  2   N 70 2   N -02   N 74- 2 c#  N  4.'-- f -- f -  2 f f  75 2  f  -52  f  79- 2 c f   9.'--  --  -  2    80 2 C   -02 S   84- 2 c    4.'--`  --`  -  2   _ 85 og - 2 c;  _  -'--H  --H  -  2   G eldri  - 2 /  G  ,'--y.--x.@"Antique Olive Romanbw0-  2 4 .xAldursbil  - 2 .x ,'- - ' d- - - - |- - --!>-->-  2 =Karlar - 2  = ,'- - bC- - --!m--m-  2 mmKonur- 2 m ,'-  --'&'-6 WPC)22"513980! !2t) &WordMicrosoft Word  i  "System 0- @Times New Romanbwbw0-i & j.  --ii   UA   ''  ----'-- --'-- --'--  Arialw@! 5bwbw0- "Systemw@) {bwbw0- Arialw@! 6bwbw0----'--  Arialw@, bwbw0- -  Arialw@, bwbw0- ---'--  Arialw@I lbwbw0- -------- -- -- -- -Arialw@ .bwbw0- ---'--  Arialw@ bwbw0- - -- -- - -- -- - -- -- - -- --  Small Fonts bwbw0-  Arialw@ >bwbw0-- -- ---------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- --------- - -- -- -- -- ----------- - -- -- -- -- ---'- --  ---'- --  --  $exxeex----'- --  seseCe Cee]e]eexex---'- --  k-xe xexe---'- --  ---'- --   ---'- --  xe---'- --  ue-33- 33 $o~~oo$$$   $<KK<<$nt}t}nnt$ggg$OOO$$; J J;; $o~~oo$$kkk$]]]$:WIWI::W$n}}}}nn}$$- $~~~$$$''$K{Y{YKK{$}kk}}k$QQQ$,,,$&&$JYYJJ$~GG~~G$   $$%%$IXXII$}}}$$---'- --  xe---'- --  -xe e-beCbCebebe]b]ebebexbxeeee22dd11ee00dd----------'---  Ow  Z2 >7N05B - Randi og kvastillandi lyf (anxiolytica) m          2 4y^Fjldi skilgreindra dagskammta 1000 ba skipt eftir kyni og aldri sust 6 mn. rsins 2001                            -----'---  ---'---  ----'---    2 T02 9:2.0002 :4.0002 :6.0002 T:8.0002 210.0002 212.0002 o214.000---'---  ---'---    2 s0-4. 2 5-9.2 10-14.2 15-19.2 920-24.2 l25-29.2 30-34.2 35-39.2 40-44.2 845-49.2 k50-54.2 55-59.2 60-64.2 65-69.2 870-74.2 k75-79.2 80-84.2 85 og2 eldri.---'---  - -- -- ---'- --  S 2  Aldursbil   -- ---'- --  -- -- ---'- --  0  Arialw@ bwbw0-B2 'DDD hverja 1000 ba hvers aldursbils            - -- ---'- --  - -  k---'- --  j---'- --  j-33- 33  2 Karlar ---'- --  j---'- --  j--  ;3 2 ?Konur ---'- --  j---'- --  ---'- --  ---'  ' '  --'     --'&' 2   i --&d9 Z6Times New Roman Regular P at'ISUS.,,,..XXXX? :,XX0?vvbX0#ggdd  ISIS,.   _Ԁ__: WPC!D ƚX      ''  '  '   Arialw@ Ubwbw0- "System 0-'- k s2 HHeildarnotkun randi og kvastillandi lyfja sustu 6 mn. risins 2001B383$88388$8388883283338813388383R383$3833333-'-  -'- s ]2 k9mld skilgreindum dagskmmtum (DDD) eftir kyni og aldrinRR8338$3888R838338RR8RBBB3$3188838$-'-   Arialw@" bwbw0- 2  Aldursbil-))%)2 gKarlar0%%2 Konur0)))2 /Bi kyn0<)%")2 2Karlar0%%2 Konur0)))2  Bi kyn0<)%") Arialw@ Dbwbw0- 2 0-4** 2 551*** 2 B398*** 2 948***2 58,1%***C2 41,9%***C 2 x 0,1%**C 2 5-9%** 2 381%*** 2 B336%*** 2 718%***2 53,1%***C2 46,9%***C 2 x 0,1%**C2 t10-14**** 2 3941*** 2 B5581*** 2 9521***2 41,4%***C2 58,6%***C 2 x 0,1%**C2 Ot15-19**** 2 O5891***2 O1.587****2 O2.176****2 O27,1%***C2 O72,9%***C 2 Ox 0,2%**C2 t20-24****2 j4.131****2 5.861****2 9.992****2 41,3%***C2 58,7%***C 2 x 1,1%**C2 t25-29****2 j7.766****2 10.165*****2 r17.931*****2 43,3%***C2 56,7%***C 2 x 2,0%**C2 t30-34****2 @10.788*****2 15.882*****2 r26.671*****2 40,4%***C2 59,6%***C 2 x 3,0%**C2 t35-39****2 @18.314*****2 28.175*****2 r46.489*****2 39,4%***C2 60,6%***C 2 x 5,2%**C2 Rt40-44****2 R@32.539*****2 R42.114*****2 Rr74.653*****2 R43,6%***C2 R56,4%***C 2 Rx 8,3%**C2 t45-49****2 @34.622*****2 60.402*****2 r95.025*****2 36,4%***C2 63,6%***C2 N 10,6%***C2 t50-54****2 @38.375*****2 71.185*****2 H109.560******2 35,0%***C2 65,0%***C2 N 12,2%***C2 t55-59****2 @46.991*****2 67.653*****2 H114.644******2 41,0%***C2 59,0%***C2 N 12,8%***C2 t60-64****2 @37.487*****2 51.952*****2 r89.439*****2 41,9%***C2 58,1%***C2 N 10,0%***C2 Ut65-69****2 U@35.928*****2 U57.944*****2 Ur93.872*****2 U38,3%***C2 U61,7%***C2 UN 10,5%***C2 t70-74****2 @34.785*****2 57.402*****2 r92.187*****2 37,7%***C2 62,3%***C2 N 10,3%***C2 #t75-79****2 #@21.893*****2 #40.619*****2 #r62.512*****2 #35,0%***C2 #65,0%***C 2 #x 7,0%**C2 t80-84****2 @13.005*****2 26.353*****2 r39.358*****2 33,0%***C2 67,0%***C 2 x 4,4%**C2 $ 85 og eldria******2 j5.864****2 13.735*****2 r19.599*****2 29,9%***C2 70,1%***C 2 x 2,2%**C2 X Samtals2*?*&2 X 344.402******2 X 552.321******2 X H896.724******2 X 38,4%***C2 X 61,6%***C2 X $ 100,0%****C--'- P   y2 LKostnaur almannatrygginga og sjklinga vegna randi og kvastillandi lyfjaB838388$3R3883$1888838838388323883$8388883283338813-'-  Arialw@[ bwbw0- 2 xRandi og kvastillandi lyf eru skv. regluger nr. 948/2000 ekki greidd af almannatryggingum, nema fyrir sjklinga me <......+)..*...'..*+)...............++......G....'.....G..G.'*.+...G..K2 & -sjkdm lokastigi ( sjklingar me Q-kort).h*.+..G..+.*.*.+...G..A+.--'- hA 2 Q[ Fjldi DDD)))000-'- 3 Ah 2 Q`Hlutfall0)%-'-  -'-  - -- !o-=- !=-- - !_-I I d- !\I -  d- !\ - - !--Ed d- !kEd-E/  / - !sE/ -- - !- - !--  - !  -==7 - ! =-7 - !/ -  7 - !/ -I lI 7 - !I l- d 7 - ! d--'-  -'-  -4 --'(3{a$ ]!ISUS.,,,..TRV<6&A4V<6&A4 6&A4 6&A4T  )!dxdx( $ Figure  1  ikmo %Eu{}1. a. 1.StafliWir undir t?luliW1.a.1.()3t$ Z!ISUS.,,,..TRV<6&A4X3' Letter 6&A43'TXXXXTRV<6&A4V<6&A4 6&A4 6&A4T ? )XX0?vvbX0#ggdd  8]dXXd8ISIS,.     ()3t$ Z!ISUS.,,,..TRV<6&A4X3' Letter 6&A43'TXXXXTRV<6&A4V<6&A4 6&A4 6&A4T ? )XX0?vvbX0#ggdd  8]dXXd8ISIS,.     (53$ Z!ISUS.,,,..TRV<6&A4X3' Letter 6&A43'TXXXXTRV<6&A4V<6&A4 6&A4 6&A4T ? )XX0?vvbX0#ggdd  8]dXXd8ISIS,.      d (M0J$2  0  .3  0 ` (O;$0  2#  a  .3  0` (#(#(u$0  0` (#(#` `  2  a  .3  0` (#` (#(`$0  0` (#(#0 ` (#` (#0 (# (#"h2  0  .3  0(#(#3#37=CIQYag1.a.i.(1)(a)(i)1)a)  at'ISUS.,,,..XXXX? :,XX0?vvbX0#ggdd  ISIS,.   _>? :,:,.P@S:\128\a\skjol\0927-svar.222.wpdPS:\128\a\skjol\0927-svar.222.wpd/  #:,:,K#6  2d  z:,0vinnslu#:, z1#d2%  d , g+ISUS.,,,..XXXX? :,XX0?vvbX0#ggdd  ISIS,.   d  ݀qi) %y_ gEu{}a. 1. a.T?luliWur undir stafliWa.1.a.1)a)4cp Z "Times Regular L et)ISUS.,,,..XXXX? :,XX0?vvbX0#ggdd  ISIS,.   _>? Ҁ  Z!ISUS.,,,..TRV<6&A4X3' Letter 6&A43'TXXXXTRV<6&A4V<6&A4 6&A4 6&A4T ? :,XX0?vvbX0#ggdd  8Idd8ISIS,.     _ >?  _ikmo(%03q_s8_2 9128.lggjafarYing2002!2003. ( Xskj.927"222.ml.     z:,@"Svar#:, z#   heilbrigWisrWherraviWfyrirspurnSigrWar_Ingvarsd;ttur_Ԁumnotkun_Yunglyndislyfja_.     Fyrirspurninhlj;Warsvo: K #    Hvererrlegnotkun_Yunglyndislyfja_ԀeWa_geWlyfja_Ԁhrlandi,sundurliWaWeftirkyniog    aldrinotenda?      undanfrnumrumhafatlurumnotkunlyfjabyggstupplUsingumumslulyfja wO  _heildslu_.MeWtilkomu_gagnagrunns_ԀTryggingastofnunarrkisins,_TR_,erunntaWsvara B  spurningumeinsogYeirrisemhrumrWirogerhanneittYeirratkjasemnotamtilaW    fylgjastmeWYr;un_lyfjakostnaWar_Ԁhrlandi.     EinsogstaWanernnanUtist_gagnagrunnur_Ԁ_TR_Ԁekkisemskyldi,YvaWeinungiserunnt {  aWgreinaafgreiWslulyfjaeftirkyniogaldri,enekkiraunveruleganfjldaeinstaklingaYv nF aW_kennitlur_ԀYeirraeru_dulk;WaWar_ԀtilviljanakenntviWhverjaafgreiWslu,enekkieinshverju 9 sinni.XessvegnaerekkiunntaWgreinahversumargireinstaklingareruhverju_aldursbili_,  heldureinungishversuofteinstaklingarviWkomandialdrihafafengiWafgreiddlyf,YvaW  samieinstaklingurgeturfengiWafgreiWsluoftareneinusinniri.LagtverWurframfrum r varptilbreytingalyfjalgumYarsem_TR_ԀverWurheimilaWaW_dulk;Wa_Ԁ_kennitlur_Ԁeinstak e= lingaeinshverjusinni. 0   Afeftirfarandilnuritimsjnotkun_geWdeyfWarlyfja_,_Y.e._Ԁfjldaskilgreindra_dags  skammta_Ԁ(_DDD_)hverja1.000baskipteftiraldriogkynifyrirriW2001.LnuritiWer  Yeim_annmrkunum_ԀhWaWYaWtekureinungistilum94%_lyfjanotkunar_Ԁumrddumflokki, i enum6%lyfjannaerunotuWsjkrahsum. \4   _lnuritinu_ԀkemurframaW0,9%afheildarnotkunYessaralyfjaernotuWviW_ofvirkni ' rskun_Ԁbrnumnuraogyngri.0_LknablaWinu_Ԁ2000;86:337!342ergreintfrgreiningu  og_meWferWarrrWum_Ԁ102barnasemkomubarna-og_unglingageWdeild_ԀLandsptalans  vegna_ofvirknieinkenna_Ԁfr1.jn1998til31.ma1999.0inngangigreinarinnarsegiraW `  greiningogmeWferWviW_ofvirknirskun_Ԁhafiaukistmjgundanfrnumrum,enltiWs S+! vitaWum_meWferWarhefWir_ԀhrlandiogergreininnireyntaWvarpalj;siYrogYau " rrWi,semnotuWeruhrogerlendis.0niWurstWugreinarinnarsegirsWan:?Allsgreindust # 72brnmeW_ofvirknirskun_.Algengasta_fylgirskunin_Ԁvarm;tYr;a-Yrj;skurskunbWi  $ Yeimh;pibarnasemgreindustmeW_ofvirknirskun_ԀogYeimsemfenguaWrafyrstugreiningu. !W% HjumtalsverWumhlutah;psinsgreindusteinnig_tilfinningaraskanir_.AlgengastvaraWlyfja J""& meWferWvrihafinmillifjgurraogttaraaldurs._Amitryptilin_Ԁog_methylphenidat_Ԁvoru #' oftastvalinsemfyrstameWferW,ennnurlyfvorumunsjaldnarnotuWoghj35%barnanna #( hafWilyfjameWferWekkiveriWreynd.ViWkomuvoru56brnlyfjameWferWog11Yeirra $ ) fengufleirieneittlyf.Algengasta_slflagslega_Ԁ_meWferWarrrWiW_ԀvaraWbj;Waforeldrum v%N!* uppsrstk_rWgjafarviWtl_._Nstalgengast_ԀvaraW_meWferWartilboW_Ԁum_YjlfunarnmskeiW_ A&"+ og_frWslunmskeiW_.   '",   &  XessskalgetiWaWnotkun_geWdeyfWarlyfja_Ԁgegn_ofvirkni_ԀhefurminnkaWjafnhliWaaukinni '#- notkunrvandilyfja.'' (z$. 9 y_     riW2001afgreiddulyfjaverslanirsemsvarar73,7afskilgreindumdagskmmtumaf ( geWdeyfWarlyfjumfyrirhverja1000ba,eWatplega94%afskrWrislu.Tplega/--//244kk3///hlutar  (63,4%)lyfjavsanavorutilkvenna.LnuritiWsUnirskiptinguvsaWraskammtamillikynja  fimmraaldursbilum. a  >?>?>> >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >>>?>?s 3?/+b|1 L3 ` @EjTL(s߰  Konurfengu74%fleiridagskammtaenkarlarheild,mismunandieftiraldri.Fleiriungir  drengirenstlkurfengugeWdeyfWarlyf,enviWkynYroskaaldur_verWakonurvaxandimeiri i hlutaframundirttrttermunurinnminnkaraftur.Kyn-ogaldursdreifinginersvipuWog \4 ranns;knumfr1984,1989og1993aWYvfrtlduaWvsanirtilbarnaundir15raaldri ' voruYhverfandi(T;masHelgason,JlusK.Bjrnsson,HaraldurS.XorsteinssonogHelgi  T;masson:PsychopharmacoepidemiologyinIceland;effectsofregulationsandnew  medications.EurArchPsychiatryClinNeusosci1997;247:93!99).HinsvegarhefurvsaW `  magnaukistmeiraenframkomlitinefndarsemheilbrigWisrWherraskipaWi1999tilaW S+! fjallaumnotkungeWdeyfWarlyfjaogYunglyndisraskanir(LknablaWiW1999;85.rg.Fylgirit " 38). #   AlgengiYunglyndisraskanaogYunglyndiseinkennaertvisvarsinnummeirahjkonum  $ enkrlum.Xvkemurekki;vartaWfleirikonumsvsaWgeWdeyfWarlyfjum.Algengi !W% YunglyndiseykstekkimeWhkkandialdri.Hinsvegarkomakonurogeldraf;lkoftartil J""& lknaogkannYaWaWvaldanokkruumhvemargtf;lkyfirsextugtfrgeWdeyfWarlyf. #' HmarknotkunargeWdeyfWarlyfjannahjkonumeraldrinum55!59raenhjkrlum #( 80!84ra.Samkvmterlendumranns;knumeralgengiYunglyndiseinkennaum10%hj $ ) krlumog20%hjkonum.ViWranns;knhrlandirinu1984fundusteinkennisem v%N!* bentutilYunglyndis-og/eWakvWaraskanahj14%karlaog17%kvennaaldrinum20!59 A&"+ ra.AlgengigeWraskanaermeirahjdrengjumundir15raaldrienhjstlkum.  '",   &  GeWdeyfWarlyferufyrstogfremstnotuWviWYunglyndisrskunumog-einkennum,en '#- sWarirumhafa''*YauveriWnotuWviWWrumgeWkvillumogeinkennumvaxandimli,m.a. (z$. ____hjbrnumundir15raaldri.MYarnefnaaWkveWintegundgeWdeyfWarlyfjahefurreynst ( gagnlegviWathyglisbrestiogskyldumgeWrskunummeWalbarna.SkUrirYaWaWeinhverju  leytinotkuninayngstualdursh;punum.    HreftirfylgjaeinniglnuritsemsUnalyfjanotkunskyldralyfjaeWar;andiogkvWa a stillandilyfja(anxiolytica,ATCflokkurN05B)ogsvefnlyfjaogr;andilyfja(hypnoticaog T, sedativa,ATCflokkurB05C).lnuritunumsst,aWnotkunineykstmeWhkkandialdri,  nrhmarkiogfersWanlkkandi.Notkunr;andiogkvWastillandilyfjahefstaldrinum  75!79ra,enseinnaflokknumsvefnlyfogr;andilyfeWaviW80!84raaldur.Xnota   konurmeiraafYessumlyfjumenkarlar.Xessilyferuekkigreiddafalmannatryggingum,  X nemafyrirsjklingameWsjkd;mlokastigi. K #  w 5C3/b~0 t `2@E t/ t/ t  ww 5C3/b~0 Kt `2@Es t/ t/ t(  w w 5C3/b~0 Kt `2@Es t/ t/ t(  w  w 5C3/b~0 KM `2@Es Mh Mh (  w  5N>:@b~0 KM `2@ Es Mh Mh (  q 9=-)`~0 Ct> `Ett\ q q 9=-)`~0 ]t> `Ett: q   q 9=-)`~0 t> `Ett q   q 9=-)`~0 t> `Ett[ q ~ 9H84@`~0 t> ` Ett[ ~     w C3/b~1 @M  `v@EhMM(w >?>?>> >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >?>?>?>? >>>?>?w C3/b~1   `v@E 66vw